Association of Recent Use of Non–Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase
Author(s) -
Wayneho Kam,
DaJuanicia N. Holmes,
Adrian F. Hernandez,
Jeffrey L. Saver,
Gregg C. Fonarow,
Eric E. Smith,
Deepak L. Bhatt,
Lee H. Schwamm,
Mathew J. Reeves,
Roland Matsouaka,
Yosef Khan,
Martin Unverdorben,
Mary C. Birmingham,
Patrick D. Lyden,
Andrew W. Asimos,
Dorothea Altschul,
Timothy L. Schoonover,
Mouhammad Jumaa,
Jason T. Nomura,
M. Fareed K. Suri,
S. Arthur Moore,
E. Francis LaFranchise,
DaiWai M. Olson,
Eric D. Peterson,
Ying Xian
Publication year - 2022
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2022.0948
Subject(s) - medicine , vitamin k antagonist , stroke (engine) , retrospective cohort study , emergency medicine , cohort , cohort study , pediatrics , physical therapy , anesthesia , warfarin , atrial fibrillation , mechanical engineering , engineering
Current guidelines recommend against use of intravenous alteplase in patients with acute ischemic stroke who are taking non-vitamin K antagonist oral anticoagulants (NOACs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom